These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22771300)

  • 41. [New antithrombotic drugs].
    Le Heuzey JY
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S64-6. PubMed ID: 20103187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Re: New guidelines for antithrombotic therapy and thromboprophylaxis].
    Stormorken H
    Tidsskr Nor Laegeforen; 2014 Jul; 134(12-13):1216. PubMed ID: 24989189
    [No Abstract]   [Full Text] [Related]  

  • 43. Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy.
    Lichtenstein AH
    Thromb Res; 2005; 117(1-2):71-3; discussion 113-5. PubMed ID: 15951007
    [No Abstract]   [Full Text] [Related]  

  • 44. Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.
    Sabatier B; Trinquart L; Emmerich J
    Arch Cardiovasc Dis; 2010 Oct; 103(10):497-501. PubMed ID: 21130962
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical implications for patients on antithrombotic therapy while taking supplements.
    Ortel TL
    Thromb Res; 2005; 117(1-2):75-80; discussion 113-5. PubMed ID: 15961141
    [No Abstract]   [Full Text] [Related]  

  • 46. [Deficient thrombosis prophylaxis].
    Holme PA
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1176. PubMed ID: 17479132
    [No Abstract]   [Full Text] [Related]  

  • 47. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1984 Oct; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticancer treatment and thrombosis.
    Falanga A; Marchetti M
    Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antithrombotic therapy in patients with left ventricular assist devices: a critical view of the data and lessons from the past.
    Charitos EI; Sievers HH
    Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):505; discussion 505-6. PubMed ID: 20858659
    [No Abstract]   [Full Text] [Related]  

  • 50. Antithrombotic therapy in congestive heart failure.
    Cokkinos DV
    J Cardiovasc Risk; 1995 Apr; 2(2):89-90. PubMed ID: 7606655
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention and treatment of deep venous thrombosis.
    Ortel TL
    Vascular; 2008; 16 Suppl 1():S64-70. PubMed ID: 18544309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thromboprophylactic management in the neurosurgical patient with high risk for both thrombosis and intracranial bleeding.
    Niemi T; Armstrong E
    Curr Opin Anaesthesiol; 2010 Oct; 23(5):558-63. PubMed ID: 20717013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
    Freudenberger RS; Fuster V
    Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540
    [No Abstract]   [Full Text] [Related]  

  • 54. Response to Dr Junqueira.
    Linkins LA; Dans AL; Moores CLK; Davidson BL; Schulman S; Crowther M
    Chest; 2013 Apr; 143(4):1191. PubMed ID: 23546509
    [No Abstract]   [Full Text] [Related]  

  • 55. American College of Chest Physicians guidelines for heparin-induced thrombocytopenia: a need for evidence-based assessment of the baseline risk of heparin-induced thrombocytopenia.
    Junqueira DRG
    Chest; 2013 Apr; 143(4):1190-1191. PubMed ID: 23546508
    [No Abstract]   [Full Text] [Related]  

  • 56. Guidelines and conflicts: a new twist.
    Nathanson I
    Chest; 2013 Oct; 144(4):1087-1089. PubMed ID: 24081334
    [No Abstract]   [Full Text] [Related]  

  • 57. New antithrombotic agents and the need for updated ophthalmic surgery guidelines.
    Wijetilleka S; Ramskold L
    Eye (Lond); 2015 Aug; 29(8):1114. PubMed ID: 25976639
    [No Abstract]   [Full Text] [Related]  

  • 58. [Prevention of thrombosis, Part I, II and III by Angelika Zegelin and Andreas Gerlach, "Pflege Actuell" II and 12/95 and 1/96].
    von Stösser A
    Pflege Aktuell; 1996 Apr; 50(4):266-7. PubMed ID: 8715820
    [No Abstract]   [Full Text] [Related]  

  • 59. [Synthetic antithrombotic drug with broad approval profile].
    Ameri AA
    MMW Fortschr Med; 2015 Feb; 157(3):68. PubMed ID: 25743677
    [No Abstract]   [Full Text] [Related]  

  • 60. Topically applied antithrombotic agents offer a new therapeutic approach to the prevention of microvascular thrombosis.
    Cooley BC; Gould JS
    Microsurgery; 1991; 12(4):281-7. PubMed ID: 1895938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.